1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cyclosporine as Therapy for Traumatic Brain Injury
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
(
- Contribution to journal › Article
- 2020
-
Mark
Antidiabetic xanthones with α-glucosidase inhibitory activities from an endophytic Penicillium canescens
(
- Contribution to journal › Article
- 2014
-
Mark
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors : preclinical assessment
2014) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 55(11). p.8-1842(
- Contribution to journal › Article
- 2011
-
Mark
Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease
(
- Contribution to journal › Article
-
Mark
Animal modelling of traumatic brain injury in preclinical drug development : where do we go from here?
(
- Contribution to journal › Scientific review